Dexcom | DXCM - Current Assets

Stock Price
71.64
Daily Change
-0.89 -1.23%
Monthly
5.90%
Yearly
-18.09%
Q1 Forecast
70.79

Dexcom reported $5.22B in Current Assets for its fiscal quarter ending in September of 2025.





Current Assets Change Date
Abbott USD 24.84B 371M Sep/2025
Align Technology USD 2.53B 86.04M Sep/2025
AtriCure USD 301.11M 29.85M Sep/2025
Avanos Medical USD 351.4M 4.6M Sep/2025
Baxter International USD 6.93B 184M Sep/2025
Becton, Dickinson and Co. USD 9.26B 258M Sep/2025
Boston Scientific USD 8.04B 914M Sep/2025
Cooper Companies USD 2.11B 31.4M Sep/2025
Dexcom USD 5.22B 189.3M Sep/2025
Edwards Lifesciences USD 6.36B 218.3M Sep/2025
Globus Medical USD 1.92B 194.46M Sep/2025
Hologic USD 3.84B 175.3M Dec/2025
Insulet USD 1.86B 420.3M Sep/2025
Integra LifeSciences USD 1.14B 754K Sep/2025
J&J USD 54.61B 113M Sep/2025
Masimo USD 1.05B 221.5M Sep/2025
Medtronic USD 23.22B 591M Jun/2025
Merit Medical Systems USD 985.53M 62.46M Sep/2025
Roche Holding CHF 38.73B 3.03B Dec/2025
Solventum Corp USD 4.41B 1.2B Sep/2025
Stryker USD 14.76B 1.04B Dec/2025
Tandem Diabetes Care USD 616.94M 2.13M Sep/2025
Teleflex USD 1.99B 262.12M Sep/2025
West Pharmaceutical Services USD 1.82B 142.4M Sep/2025
Zimmer Biomet Holdings USD 5.83B 781M Sep/2025